SEC Form 5 · accession 0001477932-17-003733
Innovation Pharmaceuticals Inc. · IPIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Arthur Peter Bertolino
Officer — Pres. & Chief Medical Officer
Period of report
Jun 30, 2017
Accepted (ET)
Aug 8, 2017 · 4:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001355250
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Jun 27, 2017 | F | 262,080 | $0.84 | D | 804,587 | D |
Table II — derivative securities
No Table II lines on this filing.